drugset / Trial / NCT02185040
A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether CC-220 is effective for the treatment of skin, joint and serological manifestations of systemic lupus erythematosus.
Timeline
- Start
- 2014-09-16
- Primary completion
- 2018-09-25
- Completion
- 2018-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iberdomide | Small molecule | 0.3 mg | Oral |
| Subject | Iberdomide | Small molecule | 0.6 mg | Oral |